Eiko LifeSciences Ltd manufacturing & sells Specialty Chemical and Fine ChemicalsBusiness Overview: ELL is in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and Fine Chemicals comprising organic & inorganic chemicals, and Pharma Intermediates, etc.
Eiko LifeSciences Limited has informed shareholders without registered email addresses about accessing the 48th Annual General Meeting (AGM) notice and Annual Report for FY2024-25. The company sent letters providing a weblink and QR code for these essential documents. The AGM will be held via video conferencing/other audio-visual means. This ensures...
Eiko Lifesciences has completed the distribution of its Annual Report and Notice for the upcoming 48th Annual General Meeting. The meeting will be held virtually via Video Conference/Other Audio-Visual Means. Shareholders can access the documents on the company's website, the RTA's website, and the BSE website. The company has also...
Eiko Lifesciences has announced the financial results for the quarter. The company's Board of Directors approved the unaudited standalone and consolidated results. For the standalone performance, Total Income from Operations stood at ₹0.81 Cr, with a Net Profit after tax of ₹0.69 Cr, and Basic EPS at ₹0.50. On a...
Eiko LifeSciences' Board has approved a significant increase in its Authorized Share Capital from 14 Cr to 20 Cr, split into 2 Cr equity shares of Rs 10 each. This move, which requires shareholder approval, alters the company's Memorandum of Association. This capital increase provides Eiko LifeSciences with greater flexibility...
Eiko LifeSciences has announced that its Board of Directors noted the resignation of Mr. Umesh More from his role as Whole Time Director. His departure is effective from the close of business hours on the day the Board met, attributed to his pre-occupation and focus on other business endeavors. This...
